We are live on ! Find out more
IFRX icon

InflaRx

37 hedge funds and large institutions have $33.1M invested in InflaRx in 2021 Q2 according to their latest regulatory filings, with 5 funds opening new positions, 4 increasing their positions, 15 reducing their positions, and 10 closing their positions.

New
Increased
Maintained
Reduced
Closed

12% less funds holding

Funds holding: 4237 (-5)

29.9% less ownership

Funds ownership: 55.36%25.46% (-30%)

41% less capital invested

Capital invested by funds: $56.4M → $33.1M (-$23.2M)

50% less first-time investments, than exits

New positions opened: 5 | Existing positions closed: 10

71% less call options, than puts

Call options by funds: $94K | Put options by funds: $321K

73% less repeat investments, than reductions

Existing positions increased: 4 | Existing positions reduced: 15

Holders
37
Holders Change
-5
Holders Change %
-11.9%
% of All Funds
0.64%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
5
Increased
4
Reduced
15
Closed
10
Calls
$94K
Puts
$321K
Net Calls
-$227K
Net Calls Change
-$141K

IFRX Hedge Fund Activity: Q2 2021 in Review

37 of the 5,746 institutional investors tracked by Wall St. Rank reported a position in InflaRx (IFRX) for Q2 2021, worth a combined $33.1M — down 41% from $56.4M a quarter earlier.

Sellers outnumbered buyers: 10 funds closed out of IFRX and 5 opened new positions — a net loss of 5 holders — while 15 trimmed existing stakes and 4 added.

The largest buyer was Bank Julius Baer & Co, opening a new position worth an estimated $655K. The largest seller was Sphera Funds Management, exiting entirely with an estimated $3.9M sold.

  • 37 institutional investors held InflaRx (IFRX) as of Q2 2021, down from 42 in Q1 2021.
  • Funds reported $33.1M of InflaRx stock for Q2 2021, down 41% quarter-over-quarter.
  • 5 funds opened new InflaRx positions in Q2 2021 and 10 closed out, a net change of -5 holders.
  • The largest InflaRx buyer in Q2 2021 was Bank Julius Baer & Co, an estimated $655K added.
  • The largest InflaRx seller in Q2 2021 was Sphera Funds Management, an estimated $3.9M sold.

Based on aggregated 13F filings for Q2 2021.